Focus on the development and commercialization of new drugs for perioperative anesthesia, analgesia and anti-inflammation.

Cali Biosciences

We are an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have several patented technology platforms and an international team of scientific research and management talents. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia and anti-inflammatory. In the future, we will also promote the commercialization of products to fully respond to the unmet market demand.

More

R&D PipelineCali Biosciences has built a pipeline of products including multiple drug candidates.

More

Technology platformCali Biosciences possesses multiple patented drug delivery technology platforms.

More

R&D CenterThe drug R&D center of Cali Biosciences focuses on the research of complex formulations of perioperative drugs.

More

News

Cali Biosciences Announces Publication of Phase IIa Results o...

Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biopharmaceutical company focused on the research and developme...

Cali Biosciences Begins and Immediately Fulfills Initial Enroll...

Cali Biosciences Co., Ltd. (hereinafter referred to as "CaliBio"), a global biopharmaceutical company focused on the research and development...

Cali Biosciences Announces Successful Results in Phase IIb S...

SAN DIEGO, March 21, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a...